✦ LIBER ✦

Bioavailability and feasibility of subcutaneous 5-fluorouracil

✍ Scribed by Borner, MM; Kneer, J; Crevoisier, C; Brunner, KW; Cerny, T

Book ID: 109836917
Publisher: Nature Publishing Group
Year: 1993
Tongue: English
Weight: 545 KB
Volume: 68
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1993.382

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bioavailability of subcutaneous 5-fluoro

Bioavailability of subcutaneous 5-fluorouracil: a case report

✍ M. M. Eatock; W. Carlin; D. J. Dunlop; M. Soukop; D. G. Watson 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 60 KB

Subcutaneous continuous infusion of ifos

Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility

✍ T. Cerny; A. Graf; Ph. Rohner; T. Zeugin; K. W. Brunner; A. Küpfer 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 569 KB

Continuous-infusion 5-fluorouracil combi

Continuous-infusion 5-fluorouracil combined with doxorubicin and cyclophosphamide: Feasibility study

✍ Saphner, Thomas ;Tormey, Douglass C. ;Carey, Patrick 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

## Abstract Previous studies have demonstrated continuous‐infusion 5‐fluorouracil (Cl 5‐FU) to be an active single‐agent treatment for breast cancer without significant myelotoxicity. These qualities made Cl 5‐FU an attractive agent for combination with other effective but myelosuppressive agents.

Combined intra-arterial 5-fluorouracil a

Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma

✍ Bazarragchaa Damdinsuren; Hiroaki Nagano; Morito Monden 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

5-Fluorouracil and derivatives in cancer

5-Fluorouracil and derivatives in cancer chemotherapy: Determination of 5-fluorouracil in blood

✍ J. J. Windheuser; J. L. Sutter; E. Auen 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

Feasibility of dose–intensive continuous

Feasibility of dose–intensive continuous 5–fluorouracil, doxorubicin, and cyclophosphamide as adjuvant therapy for breast cancer

✍ Georgiana Ellis; Robert B. Livingston 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views